EC Top Precision Medicine Stocks

For investors, there are a few stocks that participate in this industry.

Illumina (ILMN) makes and sells sequencing systems for for genomic analysis. The stock trades at 50 times trailing earnings and 46 times forward earnings. Earnings for the latest reported quarter were up 12%.

Vermillion (VRML) develops diagnostic tests, including genetics testing through its ASPiRA GenetiX platform for hereditary breast and ovarian cancer. The company is currently generating negative earnings.

Vertex Pharmaceuticals (VRTX) has developed gene therapy for treating cystic fibrosis. The stock has a price to earnings of 28 and a forward P/E ratio of 36.

Other companies involved in the precision medicine which are worth investigating are Biomarin Pharmaceutical (BMRN), IQVIA Holdings (IQV), and Loncar Cancer Immunotherapy ETF (CNCR).

Keep in mind that there are several industries that will be leaders in the future, and precision medicine will be one of them.


1 2 3
View single page >> |

Disclosure: Disclosure: Author didn’t own any of the above at the time the article was written.

Disclaimer: This article is designed to provide information. It is ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.
Leslie Miriam 9 months ago Member's comment

Interesting, the concept of precision medicine is completely new to me but it makes tremendous sense.

Fred Fuld 8 months ago Author's comment

Yes, I think it will be the top industry in the medical filed, if not one of the top industries overall.